Physician Assistant · New York, NY
NPI
1689916454
Since 2013
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave # 124
New York, NY, 10065
Phone (212) 639-8108
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
280 services
Medicare patients, 2024
199
Average age 73
Drug cost, 2024
$342K
470 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cara A Scotti was code 99214 (office e&m - established), 109 times for 87 patients. In total Cara A Scotti billed 280 services in 9 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 109 | 87 | $86.51 | $9,429 |
| 99213 Office E&M - Established | Office | 76 | 69 | $62.71 | $4,766 |
| 99215 Office E&M - Established | Office | 72 | 67 | $132.36 | $9,530 |
By year: 2022 $25K for 345 services; 2023 $14K for 197 services; 2024 $25K for 280 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cara A Scotti prescribed most often to Medicare patients was Eliquis (Apixaban), with 222 prescriptions and refills. In total Cara A Scotti wrote 470 Medicare prescriptions that cost $342K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 222 | 316 | 85 | $182K |
| Xarelto Rivaroxaban | 122 | 204 | 49 | $112K |
| Enoxaparin Sodium Generic | 104 | 129 | 47 | $28K |
Brand drugs: 351 claims; generic drugs: 119 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Cara A Scotti were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.